Hypermethylation of the p15(INK4B) gene in myelodysplastic syndromes

Blood

Volumn 90, Issue 4, 1997, Pages 1403-1409

  Uchida, Toshiki ^a   Kinoshita, Tomohiro ^b   Nagai, Hirokazu ^b   Nakahara, Yohsuke ^b   Saito, Hidehiko ^b   Hotta, Tomomitsu ^b   Murate, Takashi ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; LEUKEMIA; METHYLATION; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE; CELL CULTURE; CHEMISTRY; DNA METHYLATION; GENETICS; RESTRICTION MAPPING;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HUMANS; MYELODYSPLASTIC SYNDROMES; RESTRICTION MAPPING; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030612423     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1403     Document Type: Article

References (35)

1. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev 9275:1149, 1995
2. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704, 1993
3. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257, 1994
4. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436, 1994
5. Nobori T, Miuru K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753, 1994
6. kip2 gene at 11p15.5. Oncogene 12:1365, 1996
7. Bird A: The essentials of DNA methylation, Cell 70:5, 1992
8. Counts JL, Goodman JI: Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83:13, 1995
9. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP: Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48:880, 1991
10. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, Baylin SB: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700, 1994
11. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/ MTS1 in human cancers. Nat Med 1:686, 1995
12. INK4B. Cancer Res 56:722, 1996
13. INK4A) gene alterations in hematological malignancies. Leuk Lymphoma 24:449, 1997
14. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841, 1995
15. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL: Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res 57:832, 1997
16. INK4A characterize the major types of hematological malignancies. Cancer Res 57:837, 1997
17. Ng MHL, Chung YF, Lo KW, Wickham NWR, Lee JCK, Huang DP: Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood 89:2500, 1997
18. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: The French-American-British (FAB) co-operative group, Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189, 1982
19. Deiss A: Acquired disorders associated with hematologic malignancies, in Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds): Wintrobe's Clinical Hematology, Malvern, PA, Lea & Febiger, 1993, p 1949
20. Asano H, Ohashi H, Ichikawa M, Kinoshita T, Murate T, Kobayashi M, Saito H, Hotta T: Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood 84:588, 1994
21. Ohashi H, Ichikawa A, Takagi N, Hotta T, Naoe T, Ohno R, Saito H: Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: Molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone. Leukemia 6:859, 1992
22. Kinoshita T, Shimoyama M, Tobinai K, Itoh M, Itoh S, Ikeda S, Tajima K, Shimotohno K, Sugimura T: Detection of mRNA for tax 1/rex 1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA 86:5620, 1989
23. Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H, Murakami Y, Hayashi K, Saito H: Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 79:2701, 1992
24. Stone S, Dayananth P, Jiang P, Weaver-Feldhaus JM, Tavitigan SV, Cannon-Albright L, Kamb A: Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 11:987, 1995
25. Sill H, Aguiar RCT, Schmidt H, Hochhaus A, Goldman JM, Cross NCP: Mutational analysis of the p15 and p16 genes in acute leukaemias. Br J Haematol 92:681, 1996
26. Nakamaki T, Kawamata N, Schwaller J, Tobler A, Fey M, Pakkala S, Lee YY, Kim BK, Fukuchi K, Tsuruoka N, Kahan J, Miller CW, Koeffler HP: Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 in myeloid leukaemias. Br J Haematol 91:139, 1995
27. INK4A gene. Blood 87:1657, 1996 (letter)
28. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallepsi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Multi G, Bennett J: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079, 1997
29. Boyes J, Bird A: Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methy1-CpG binding protein. ENBO J 11:327, 1992
30. Jones PA: DNA methylation errors and cancer. Cancer Res 56:2463, 1996
31. Singer-Sam J, Grant M, LeBon JM, Okuyama K, Chapman V, Monk M, Riggs AD: Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol Cell Biol 10:4987, 1990
32. Herman JG, Graff JR, Myöhänsen S, Nelkin BD, Baylin SB: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821, 1996
33. Issa JPJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB: Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nat Genet 7:536, 1994
34. Ito T, Ohashi H, Kagami Y, Ichikawa A, Saito H, Hotta T: Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy. Leukemia 8:839, 1994
35. Delforge M, Demuynck H, Vandenberghe P, Verhoef G, Zachée P, Duppen VV, Marijnen P, Berghe HV, Boogaerts MA: Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. Blood 86:3660, 1995